Clinical Trial Update: The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF) [Phase 2, Phase 3]

View source ↗

Summary

The SNIFF study evaluating intranasal insulin for amnestic mild cognitive impairment and Alzheimer's disease has completed its Phase 2/3 portions with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Amnestic Mild Cognitive Impairment

Drugs mentioned

• Intranasal insulin (insulin)

Snippet

Sponsor: University of Southern California | Conditions: Amnestic Mild Cognitive Impairment, Alzheimer's Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-05-18